These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Britt NS; Potter EM; Patel N; Steed ME Clin Infect Dis; 2017 Mar; 64(5):605-613. PubMed ID: 28011602 [TBL] [Abstract][Full Text] [Related]
23. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin. Cunha BA; Mickail N; Eisenstein L Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808 [TBL] [Abstract][Full Text] [Related]
25. Emergence of daptomycin-resistant VRE: experience of a single institution. Kamboj M; Cohen N; Gilhuley K; Babady NE; Seo SK; Sepkowitz KA Infect Control Hosp Epidemiol; 2011 Apr; 32(4):391-4. PubMed ID: 21460492 [TBL] [Abstract][Full Text] [Related]
26. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826 [TBL] [Abstract][Full Text] [Related]
27. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary? King EA; McCoy D; Desai S; Nyirenda T; Bicking K J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178 [TBL] [Abstract][Full Text] [Related]
28. Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia. McComb MN; Collins CD Pharmacotherapy; 2014 Jun; 34(6):537-44. PubMed ID: 24390863 [TBL] [Abstract][Full Text] [Related]
29. The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection. Chuang YC; Wang JT; Yang JL; Lin CY; Huang SH; Chen YC; Chang SC J Infect Public Health; 2022 Dec; 15(12):1396-1402. PubMed ID: 36371936 [TBL] [Abstract][Full Text] [Related]
30. [Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain]. Grau S; Rebollo P; Cuervo J; Gil-Parrado S Rev Esp Quimioter; 2011 Sep; 24(3):154-63. PubMed ID: 21947099 [TBL] [Abstract][Full Text] [Related]
31. Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review. Shukla BS; Gauthier TP; Correa R; Smith L; Abbo L Int J Clin Pharm; 2013 Oct; 35(5):697-703. PubMed ID: 23893061 [TBL] [Abstract][Full Text] [Related]
32. Vancomycin-resistant Enterococcus bacteremia in a child with acute myeloid leukemia: successful treatment with daptomycin. Büyükcam A; Karadağ Öncel E; Özsürekçi Y; Cengiz AB; Kuşkonmaz B; Sancak B Arch Argent Pediatr; 2016 Dec; 114(6):e432-e435. PubMed ID: 27869427 [TBL] [Abstract][Full Text] [Related]
36. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin. Twilla JD; Finch CK; Usery JB; Gelfand MS; Hudson JQ; Broyles JE J Hosp Med; 2012 Mar; 7(3):243-8. PubMed ID: 22076962 [TBL] [Abstract][Full Text] [Related]
37. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005). Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782 [TBL] [Abstract][Full Text] [Related]